Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease
- 12 March 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
Abstract
Carriers of the hydroxysteroid 17-β dehydrogenase 13 (HSD17B13) gene variant (rs72613567:TA) have a reduced risk of NASH and cirrhosis but not steatosis. We determined its effect on liver histology, lipidome, and transcriptome using ultra performance liquid chromatography-mass spectrometry and RNA-seq. In carriers and noncarriers of the gene variant, we also measured pathways of hepatic fatty acids (de novo lipogenesis [DNL] and adipose tissue lipolysis [ATL] using 2H2O and 2H-glycerol) and insulin sensitivity using 3H-glucose and euglycemic-hyperinsulinemic clamp) and plasma cytokines. Carriers and noncarriers had similar age, sex and BMI. Fibrosis was significantly less frequent while phospholipids, but not other lipids, were enriched in the liver in carriers compared with noncarriers. Expression of 274 genes was altered in carriers compared with noncarriers, consisting predominantly of downregulated inflammation-related gene sets. Plasma IL-6 concentrations were lower, but DNL, ATL and hepatic insulin sensitivity were similar between the groups. In conclusion, carriers of the HSD17B13 variant have decreased fibrosis and expression of inflammation-related genes but increased phospholipids in the liver. These changes are not secondary to steatosis, DNL, ATL, or hepatic insulin sensitivity. The increase in phospholipids and decrease in fibrosis are opposite to features of choline-deficient models of liver disease and suggest HSD17B13 as an attractive therapeutic target.Keywords
Funding Information
- EU EPoS (634413)
- EU H2020 LITMUS (777377)
- Academy of Finland (Academy of Finland)
- EVO (EVO)
- Sigrid Juséliuksen Säätiö (Sigrid Juseliuksen Sääti)
- MIUR (MIUR)
- CNR (CNR)
- British Heart Foundation (FS/15/56/31645)
- Jalmari ja Rauha Ahokkaan Säätiö (Jalmari ja Rauha Ahokkaan Sääti)
- Paulon Säätiö (Paulon Sääti)
- Jenny ja Antti Wihurin Rahasto (Wihuri Research Institute)
This publication has 50 references indexed in Scilit:
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patientsHepatology, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progressionCurrent Opinion in Gastroenterology, 2012
- Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary cholineThe FASEB Journal, 2010
- A scaling normalization method for differential expression analysis of RNA-seq dataGenome Biology, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisJCI Insight, 2009
- Alterations of hepatic ATP homeostasis and respiratory chain during development of non‐alcoholic steatohepatitis in a rodent modelEuropean Journal of Clinical Investigation, 2008
- The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitisCell Metabolism, 2006
- Liver Damage Produced by Feeding Alcohol or Sugar and its Prevention by CholineBMJ, 1949